Role of Adverse Childhood Events and Rejection Sensitivity on Alcohol Use in Recently Withdrawn Individuals with Alcohol Use Disorder (TRAC)

February 11, 2025 updated by: Centre Hospitalier Universitaire de Nīmes

Low utilization of addiction treatment is a public health problem. A number of factors are associated with lack of treatment, including public stigma, self-stigma, and beliefs that people with addiction should solve their problem on their own. Stigma exposes individuals to social rejection, which may sustain the anxiety of rejection, and exacerbate certain mental disorders such as addictions. Social cognition disorders have been shown to be present in addictions, but one dimension of social cognition, emotional sensitivity to rejection (ESR), has been less studied. Rejection sensitivity could be considered a critical element in access to care and the relapse process.

The study authors hypothesize a role for emotional dysregulation in rejection situations in the relapse of alcohol use disorder in recently withdrawn patients. Specifically, they hypothesize that participants with a greater change in negative experience after a rejection situation on a Cyberball task, as measured by the negative subscale of the Positive and Negative Affect Schedule (PANAS), will have a higher percentage of days with heavy drinking during the last four weeks to three months of follow-up.

Study Overview

Status

Active, not recruiting

Intervention / Treatment

Study Type

Interventional

Enrollment (Estimated)

58

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Nîmes, France, 30029
        • CHU de Nîmes

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Patient admitted to the Grau-du-Roi Follow-up and Rehabilitation Care Service.
  • Patient abstinent from alcohol for at least 10 days.
  • The patient must have given their free and informed consent and signed the consent form
  • The patient must be a member or beneficiary of a health insurance plan

Exclusion Criteria:

  • Other mental health disorder: bipolar disorder, schizophrenia, severe acute depression, borderline personality.
  • Severe substance use disorder (SUD).
  • Current suicidal ideation as judged by clinician.
  • Patient unable to give consent.
  • Pregnant or breastfeeding patient.
  • The subject is participating in a Category 1 interventional study, or is in a period of exclusion determined by a previous study
  • It is impossible to give the subject informed information
  • The patient is under safeguard of justice or state guardianship

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: PAtients withdrawn from alcohol
The game consists of ball throws between animated characters lasting about 50 throws. In the rejection condition, after 2 or 3 throws, the participant no longer receives the ball (no more passes). In the control conditions ("all included"), the participant receives the ball as often as the others.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Role of emotional reaction to social rejection (Cyberball game)
Time Frame: Day 0; before Cyberball task
Positive And Negative Affect Schedule (PANAS) (negative affect score). Scores can range from 10 to 50 for positive and negative emotions, with lower scores representing lower levels of positive/negative emotional engagement and higher scores representing higher levels of positive/negative emotional engagement.
Day 0; before Cyberball task
Role of emotional reaction to social rejection (Cyberball game)
Time Frame: Day 0; after Cyberball task
Positive And Negative Affect Schedule (PANAS) (negative affect score). Scores can range from 10 to 50 for positive and negative emotions, with lower scores representing lower levels of positive/negative emotional engagement and higher scores representing higher levels of positive/negative emotional engagement.
Day 0; after Cyberball task
Percentage of heavy drinking days in the past 4 weeks
Time Frame: Month 3
Timeline Follow Back (TLFB) interview
Month 3
Correlation between percentage of heavy drinking days and the difference between the PANAS negative subscale scores at baseline and after the Cyberball task in the exclusion phase (=rejection situation).
Time Frame: Day 0; before Cyberball task
Multiple linear regression
Day 0; before Cyberball task
Correlation between percentage of heavy drinking days and the difference between the PANAS negative subscale scores at baseline and after the Cyberball task in the exclusion phase (=rejection situation).
Time Frame: Day 0; after Cyberball task
Multiple linear regression
Day 0; after Cyberball task
Correlation between percentage of heavy drinking days and the difference between the PANAS negative subscale scores at baseline and after the Cyberball task in the exclusion phase (=rejection situation).
Time Frame: Month 3
Multiple linear regression
Month 3

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Percentage of heavy drinking days in the past 4 weeks
Time Frame: Month 3
Timeline Follow Back (TLFB) interview
Month 3
Adverse childhood events
Time Frame: Day 0
Adverse childhood events (ACE) score
Day 0
Patient level of distress due to rejection
Time Frame: Day 0; after Cyberball task
Need Threat Scale (NTS) score
Day 0; after Cyberball task
Patient self-stigma due to alcohol dependence
Time Frame: Day 0
Self-stigma in Alcohol Dependence (SSAD) scale score
Day 0
Patient depression
Time Frame: Day 0
Patient Health Questionnaire (PHQ-9) score
Day 0
Patient depression
Time Frame: Month 3
Patient Health Questionnaire (PHQ-9) score
Month 3
Patient depression
Time Frame: Month 6
Patient Health Questionnaire (PHQ-9) score
Month 6
Patient depression
Time Frame: Month 12
Patient Health Questionnaire (PHQ-9) score
Month 12
Patient anxiety
Time Frame: Day 0
Generalized Anxiety Disorder-7 (GAD-7) score
Day 0
Patient anxiety
Time Frame: Month 3
Generalized Anxiety Disorder-7 (GAD-7) score
Month 3
Patient anxiety
Time Frame: Month 6
Generalized Anxiety Disorder-7 (GAD-7) score
Month 6
Patient anxiety
Time Frame: Month 12
Generalized Anxiety Disorder-7 (GAD-7) score
Month 12
Number of days of alcohol consumption in the past 4 weeks
Time Frame: Month 3
Timeline Follow Back (TLFB) interview
Month 3
Number of days of alcohol consumption in the past 4 weeks
Time Frame: Month 6
Timeline Follow Back (TLFB) interview
Month 6
Number of days of alcohol consumption in the past 4 weeks
Time Frame: Month 12
Timeline Follow Back (TLFB) interview
Month 12
Number of days of heavy alcohol consumption in the past 4 weeks
Time Frame: Month 3
Timeline Follow Back (TLFB) interview
Month 3
Number of days of heavy alcohol consumption in the past 4 weeks
Time Frame: Month 6
Timeline Follow Back (TLFB) interview
Month 6
Number of days of heavy alcohol consumption in the past 4 weeks
Time Frame: Month 12
Timeline Follow Back (TLFB) interview
Month 12
Percentage of heavy drinking days in the past 4 weeks
Time Frame: Month 6
Timeline Follow Back (TLFB) interview
Month 6
Percentage of heavy drinking days in the past 4 weeks
Time Frame: Month 12
Timeline Follow Back (TLFB) interview
Month 12
Lifetime history of suicide attempts
Time Frame: Day 0
Number
Day 0
Current treatments
Time Frame: Day 0
List of current treatments taken from patient medical file
Day 0
Patient dispositional (i.e. trait) empathy
Time Frame: Day 0
Interpersonal reactivity index (IRI) score
Day 0
Concurrent validity of the Adult rejection Sensitivity Questionnaire (A-RSQ) with the Positive And Negative Affect Schedule (PANAS) after the rejection situation.
Time Frame: Day 0; before Cyberball task
Day 0; before Cyberball task
Concurrent validity of the Adult rejection Sensitivity Questionnaire (A-RSQ) with the Positive And Negative Affect Schedule (PANAS) after the rejection situation.
Time Frame: Day 0; after Cyberball task
Day 0; after Cyberball task
Concurrent validity of the Adult rejection Sensitivity Questionnaire (A-RSQ) with the Need Threat Scale (NTS) after the rejection situation.
Time Frame: Day 0; before Cyberball task
Day 0; before Cyberball task
Concurrent validity of the Adult rejection Sensitivity Questionnaire (A-RSQ) with the Need Threat Scale (NTS) after the rejection situation.
Time Frame: Day 0; after Cyberball task
Day 0; after Cyberball task

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Amandine Luquiens, CHU de Nîmes

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 31, 2023

Primary Completion (Actual)

January 15, 2025

Study Completion (Estimated)

November 1, 2025

Study Registration Dates

First Submitted

March 13, 2023

First Submitted That Met QC Criteria

March 24, 2023

First Posted (Actual)

March 28, 2023

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

February 11, 2025

Last Verified

February 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Alcohol-Induced Disorders

Clinical Trials on Cyberball task

Subscribe